Modified RNAi polynucleotides and uses thereof

Details for Australian Patent Application No. 2009213147 (hide)

Owner RXi Pharmaceuticals Corp.

Inventors Woolf, Tod M.; Salomon, William; Khvorova, Anastasia; Pavco, Pamela A.; Kamens, Joanne

Agent Pizzeys

Pub. Number AU-A-2009213147

PCT Pub. Number WO2009/102427

Priority 61/065,335 11.02.08 US

Filing date 11 February 2009

Wipo publication date 20 August 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/102427 Priority application(s): WO2009/102427

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009213151-Searchable electronic records of underground facility locate marking operations

2009213141-Targeted therapeutics based on engineered proteins that bind EGFR